India, Aug. 21 -- iSpecimen Inc. (ISPC) announced that it completed an international cancer research order involving hundreds of blood specimens. The samples were shipped within three weeks of receiving the purchase order.
The company sourced and coordinated the specimens through its network of healthcare institutions, laboratories, biobanks and research partners. The network also supports specialised specimens, including formalin-fixed, paraffin-embedded (FFPE) and flash-frozen tissue.
CEO of iSpecimen said the delivery highlights the company's global network and helps researchers advance their projects.
Recently the company closed a public offering of common stock and pre-funded warrants for an aggregate of $5 million. iSpecimen intend...